Received Jul 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TD | TD ADSORBED (TENIVAC) | SANOFI PASTEUR | 1 | 2CA91C1 | OT / RA |
had administered an expired TENIVAC with no reported adverse event; Initial information received on 22-Jul-2025 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 64 years old male patient who received an expired diphtheria-2/tetanus-5 adsorbed toxoids NO preservative adult [tenivac] with no reported adverse event. The patient's past vaccination(s) included TDAP (diphtheria vaccine toxoid pertussis vaccine acellular tetanus vaccine toxoid) The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included varicella zoster vaccine RGE (CHO) (shingrix) for Immunisation. On 22-Jul-2025, the patient received Dose 1 of 0.5 ml of suspect diphtheria-2/tetanus-5 adsorbed toxoids NO preservative adult Suspension for injection of standard strength, frequency once with 2CA91C1 and expiry date 04-Jul-2025 via intramuscular route in the right deltoid for immunization (expired product administered) (Latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
SHINGRIX